Cigna Accounts Receivable decreased by 7.5% to $26.61B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $26.93B to $26.61B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows an upward trend with a 18.7% CAGR.
An increase relative to sales may signal slowing collections or credit risk, while a decrease suggests efficient cash conversion.
The total amount of credit extended to customers and channel partners for products sold or services rendered, minus an a...
Typically scales with revenue growth; however, companies with strong direct-to-consumer channels may have lower receivables relative to those relying on third-party distributors.
accounts_receivable_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.46B | $16.25B | $15.07B | $16.00B | $18.29B | $17.28B | $17.22B | $17.70B | $18.33B | $19.08B | $17.72B | $20.56B | $25.11B | $27.85B | $24.23B | $26.93B | $31.15B | $31.71B | $28.77B | $26.61B |
| QoQ Change | — | +5.1% | -7.3% | +6.2% | +14.3% | -5.5% | -0.3% | +2.8% | +3.6% | +4.1% | -7.1% | +16.0% | +22.1% | +10.9% | -13.0% | +11.2% | +15.7% | +1.8% | -9.3% | -7.5% |
| YoY Change | — | — | — | — | +18.3% | +6.3% | +14.2% | +10.6% | +0.2% | +10.5% | +2.9% | +16.1% | +37.0% | +45.9% | +36.7% | +31.0% | +24.0% | +13.9% | +18.7% | -1.2% |